切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06): 539 -543. doi: 10.3877/cma.j.issn.2095-3232.2021.06.001

述评

肝叶增生促进技术在剩余肝体积不足肝切除中的应用
曹磊1, 廖明恒1, 曾勇1,()   
  1. 1. 610041 成都,四川大学华西医院肝脏外科及肝移植中心
  • 收稿日期:2021-09-02 出版日期:2021-09-23
  • 通信作者: 曾勇

Liver regeneration inducing techniques in hepatectomy with insufficient future liver remnant

Lei Cao1, Mingheng Liao1, Yong Zeng1()   

  • Received:2021-09-02 Published:2021-09-23
  • Corresponding author: Yong Zeng
[1]
Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria[J]. Br J Surg, 2012, 99(12):1622-1629.
[2]
Stiles Zachary E, Behrman Stephen W, Glazer Evan S, et al. Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database[J]. HPB, 2017, 19(11):957-965.
[3]
Kong Z, Hu J, Ge X, et al. Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy[J]. Exp Ther Med, 2018, 16(3):1910-1918.
[4]
Shindoh J, Tzeng CWD, Vauthey J. Portal vein embolization for hepatocellular carcinoma[J]. Liver Cancer, 2012, 1(3/4): 159-167.
[5]
Aoki T, Kubota K. Preoperative portal vein embolization for hepatocellular carcinoma: consensus and controversy[J]. World J Hepatology, 2016, 8(9):439-445.
[6]
Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant[J]. J Gastrointestinal Surg, 2008, 12(2):297-303.
[7]
Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases[J]. Arch Surg, 2008, 143(10):978-982.
[8]
Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy:a planned strategy to treat irresectable liver tumors[J]. Ann Surg, 2000, 232(6):777-785.
[9]
Imai K, Allard M, Benitez C, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?[J]. Oncologist, 2016, 21(7):887-894.
[10]
de Santibañes E, Clavien P. Playing play-doh to prevent postoperative liver failure: the "ALPPS" approach[J]. Ann Surg, 2012, 255(3):415-417.
[11]
Schnitzbauer Andreas A, Lang Sven A, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[12]
Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? a single-center experience[J]. Ann Surg, 2015, 261(4): e90-92.
[13]
de Santibañes E, Alvarez FA, Ardiles V, et al. Inverting the ALPPS paradigm by minimizing first stage impact: the mini-ALPPS technique[J]. Langenbecks Arch Surg, 2016, 401(4):557-563.
[14]
Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure[J]. Br J Surg, 2014, 101(9):1129-1134.
[15]
Gringeri E, Boetto R, D'Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach[J]. Ann Surg, 2015, 261(2): 42-43.
[16]
Gall TMH, Sodergren MH, Frampton AE, et al. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration[J]. Ann Surg, 2015, 261(2):45-46.
[17]
Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy[J]. Ann Surg, 2009, 249(4):608-616.
[18]
Hwang S, Ha TY, Ko GY, et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy[J]. World J Surg, 2015, 39(12):2990-2998.
[19]
Munene G, Parker RD, Larrigan J, et al. Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases[J]. World J Surg Oncol, 2013(11):134.
[20]
Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique[J]. Eur Radiol, 2016, 26(12): 4259-4267.
[21]
Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg, 2006, 93(9):1091-1098.
[22]
Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection[J]. Br J Surg, 2013, 100(3):388-394.
[23]
Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach[J]. J Am Coll Surg, 2013, 217(1):126-133.
[24]
Croome KP, Hernandez-Alejandro R, Parker M, et al. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? a multicentre analysis[J]. HPB, 2015, 17(6):477-484.
[25]
Schadde E, Hernandez-Alejandro R, Lang H, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors. results of a multicentre analysis: reply[J]. World J Surg, 2015, 39(7):1510-1519.
[26]
Tanaka K, Matsuo K, Murakami T, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity[J]. European J Surg Oncol, 2015, 41(4):506-512.
[27]
Ratti F, Schadde E, Masetti M, et al. Strategies to increase resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS versus conventional two-stage hepatectomy[J]. Ann Surg Oncol, 2015, 22(6):1933-1942.
[28]
Matsuo K, Murakami T, Kawaguchi D, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization[J]. Surgery, 2016, 159(5):1289-1298.
[29]
Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection[J]. Gut, 2005, 54(2):289-296.
[30]
崔宏,高琴琴,王效益, 等. 肝细胞癌合并肝硬化患者肝切除术后标准残肝体积评估[J]. 中国现代普通外科进展, 2019, 22(4):296-299.
[31]
Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver[J]. J Am Coll Surg, 2007, 204(1):22-33.
[32]
Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry[J]. Ann Surg, 2009, 250(4):540-548.
[33]
李富贵,严律南,曾勇, 等. 中国成人标准肝体积评估公式的临床研究[J]. 四川大学学报(医学版), 2009, 40(2):302-306.
[34]
陈熙,杜正贵,李波, 等. 标准残肝体积对肝脏储备功能的评价[J]. 世界华人消化杂志, 2010, 18(17):1829-1833.
[35]
Kamiyama T, Kakisaka T, Orimo T, et al. Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus[J]. World J Hepatol, 2017, 9(36):1296-1304.
[36]
Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of45 patients[J]. Ann Surg, 2020, 271(3):534-541.
[37]
李健,文张,徐邦浩,等. 联合门静脉切除重建的ALPPS治疗肝内胆管细胞癌[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(1):62-66.
[1] 杨占宇, 卢倩. 体外肝切除自体肝移植治疗肝细胞癌[J]. 中华普通外科学文献(电子版), 2022, 16(03): 182-182.
[2] 王莹莹, 刘莉, 吕瑞兆, 柳洁, 白晓明, 井郁陌. 下腔静脉变异度为指导的围手术期容量管理在腹腔镜肝切除术中的临床应用[J]. 中华普通外科学文献(电子版), 2022, 16(03): 194-198.
[3] 顾竹劼, 胡双双, 师小伟, 马钰, 陆敏敏, 汪建胜. 老年肝癌合并肝硬化患者围手术期不同液体管理在腹腔镜肝切除术中的对比研究[J]. 中华普通外科学文献(电子版), 2022, 16(03): 199-204.
[4] 周保富, 吴乐乐, 李永红, 胡世超. 肝切除术中不同断肝方式治疗多病灶原发性肝癌的临床效果研究[J]. 中华普通外科学文献(电子版), 2022, 16(03): 205-209.
[5] 刘贤, 兰春斌, 胥彬, 徐竹林, 宋正宇. 肝切除术围手术期症状性静脉血栓栓塞症风险评估模型的建立及验证[J]. 中华普外科手术学杂志(电子版), 2022, 16(03): 319-322.
[6] 张安清, 东爱华, 李红霞, 李爱华. 三种肝血流阻断技术在腹腔镜下肝切除术中的对比研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(03): 323-326.
[7] 陈祥, 吉韬, 董仁华. 解剖性与非解剖性肝切除术治疗肝胆管结石合并肝内胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(02): 200-203.
[8] 吕彦霖, 朱昌毫, 李英, 王兴, 潘耀振. 中晚期肝癌转化治疗研究进展[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 225-230.
[9] 陈泰安, 熊永福, 徐建, 李强, 杨刚, 李敬东. 复杂肝癌腹腔镜肝切除的应用及挑战[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 239-243.
[10] 周陈杰, 王杰钦, 张健民, 冯磊, 傅超毅, 廖晖, 徐小平, 高毅. 浅谈腹腔镜解剖性肝切除手术入路和解剖标志[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 244-247.
[11] 谢静, 毛先海, 杨建辉, 段小辉, 田朕安, 张雄, 高绪照. 再次肝切除与腹腔镜微波消融治疗复发性小肝癌临床疗效比较[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 258-262.
[12] 卢文峰, 付雍, 阎凯, 袁建勇, 陈佩钦, 张海斌. 术后预防性TACE对肝内胆管细胞癌患者预后的影响[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 268-272.
[13] 陈一帆, 王晨晨, 卢杏生. 肝内胆管导管内乳头状瘤恶变伴门静脉及胆道变异一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 299-303.
[14] 江蜜, 柴楚星, 张树华, 唐勇, 胡青钢, 万赤丹, 熊俊. 微波消融联合手术切除治疗巨大肝血管瘤一例[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 320-322.
[15] 叶齐, 高志星, 张鹏杰, 张瑞阳, 杨智義, 胡欣芫, 赵成俊, 王海久, 阳丹才让, 樊海宁, 张灵强. 微波消融治疗原发性肝癌现状及疗效评价[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 323-326.
阅读次数
全文


摘要